- Gallus, Marco;
- Roll, Wolfgang;
- Dik, Andre;
- Barca, Cristina;
- Zinnhardt, Bastian;
- Hicking, Gordon;
- Mueller, Christoph;
- Naik, Venu Narayanan;
- Anstötz, Max;
- Krämer, Julia;
- Rolfes, Leoni;
- Wachsmuth, Lydia;
- Pitsch, Julika;
- van Loo, Karen MJ;
- Räuber, Saskia;
- Okada, Hideho;
- Wimberley, Catriona;
- Strippel, Christine;
- Golombeck, Kristin S;
- Johnen, Andreas;
- Kovac, Stjepana;
- Groß, Catharina C;
- Backhaus, Philipp;
- Seifert, Robert;
- Lewerenz, Jan;
- Surges, Rainer;
- Elger, Christian E;
- Wiendl, Heinz;
- Ruck, Tobias;
- Becker, Albert J;
- Faber, Cornelius;
- Jacobs, Andreas H;
- Bauer, Jan;
- Meuth, Sven G;
- Schäfers, Michael;
- Melzer, Nico
Autoimmune limbic encephalitis (ALE) presents with new-onset mesial temporal lobe seizures, progressive memory disturbance, and other behavioral and cognitive changes. CD8 T cells are considered to play a key role in those cases where autoantibodies (ABs) target intracellular antigens or no ABs were found. Assessment of such patients presents a clinical challenge, and novel noninvasive imaging biomarkers are urgently needed. Here, we demonstrate that visualization of the translocator protein (TSPO) with [18F]DPA-714-PET-MRI reveals pronounced microglia activation and reactive gliosis in the hippocampus and amygdala of patients suspected with CD8 T cell ALE, which correlates with FLAIR-MRI and EEG alterations. Back-translation into a preclinical mouse model of neuronal antigen-specific CD8 T cell-mediated ALE allowed us to corroborate our preliminary clinical findings. These translational data underline the potential of [18F]DPA-714-PET-MRI as a clinical molecular imaging method for the direct assessment of innate immunity in CD8 T cell-mediated ALE.